Patents by Inventor Alexander E. Wick

Alexander E. Wick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5023266
    Abstract: Ifenprodil and its analogues are useful for the treatment of psychoses such as schizophrenia.
    Type: Grant
    Filed: January 24, 1990
    Date of Patent: June 11, 1991
    Assignee: Synthelabo
    Inventors: Salomon Z. Langer, Jonathan R. Frost, Johannes Schoemaker, Bernard Gaudilliere, Jean Bertin, Jean Rousseau, Regis Dupont, Alexander E. Wick
  • Patent number: 4549022
    Abstract: The invention relates to 4-pyridone-3-carboxylic acid derivatives, a process for the preparation thereof and pharmaceutical compositions containing same. The 4-pyridone-3-carboxylic acid derivatives are useful as antibacterial agents and/or as agents having a stimulating activity on the central nervous system.
    Type: Grant
    Filed: November 2, 1984
    Date of Patent: October 22, 1985
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Alexander E. Wick
  • Patent number: 4521535
    Abstract: The invention relates to 4-pyridone-3-carboxylic acid derivatives, a process for the preparation thereof and pharmaceutical compositions containing same. The 4-pyridone-3-carboxylic acid derivatives are useful as antibacterial agents and/or as agents having a stimulating activity on the central nervous system.
    Type: Grant
    Filed: April 19, 1982
    Date of Patent: June 4, 1985
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Alexander E. Wick
  • Patent number: 4515814
    Abstract: New 3-phenoxypropan-2-ol derivatives of the formula: ##STR1## wherein R represents a cycloalkyl radical having 5 or 6 carbon atoms, X represents an oxygen atom or a bond, and R' represents the isopropyl or tert.-butyl radical, have been found to be useful in therapy, and more particularly in the treatment of cardiovascular diseases and glaucoma.
    Type: Grant
    Filed: August 30, 1982
    Date of Patent: May 7, 1985
    Assignee: Synthelabo
    Inventors: Alexander E. Wick, Jean Binet
  • Patent number: 4430334
    Abstract: Phenethanolamine derivatives in the (+)-erythro form of the formula: ##STR1## wherein X represents a halogen atom, are new compounds useful in therapy.
    Type: Grant
    Filed: April 13, 1982
    Date of Patent: February 7, 1984
    Assignee: Synthelabo
    Inventors: Alexander E. Wick, Jonathan R. Frost
  • Patent number: 4374261
    Abstract: 1-Ethyl-1,4-dihydro-6-(2-naphthyl)-4-oxonicotinic acid and C.sub.1-6 -alkyl esters thereof as well as their alkali metal, alkaline earth metal or ammonium salts are described. The foregoing compounds are useful as central nervous system stimulants. Also described are 1-ethyl-6-(2-naphthyl)-4-oxo-1,4,5,6-tetrahydronicotinic acid and C.sub.1-6 -alkyl esters thereof, which are useful as intermediates.
    Type: Grant
    Filed: October 28, 1981
    Date of Patent: February 15, 1983
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Alexander E. Wick
  • Patent number: 4314063
    Abstract: 1-Ethyl-1,4-dihydro-6-(2-naphthyl)-4-oxonicotinic acid and C.sub.1-6 -alkyl esters thereof as well as their alkali metal, alkaline earth metal or ammonium salts are described. The foregoing compounds are useful as central nervous system stimulants. Also described are 1-ethyl-6-(2-naphthyl)-4-oxo-1,4,5,6-tetrahydronicotinic acid and C.sub.1-6 -alkyl esters thereof, which are useful as intermediates.
    Type: Grant
    Filed: February 19, 1981
    Date of Patent: February 2, 1982
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Alexander E. Wick
  • Patent number: 4278798
    Abstract: 1-Ethyl-1,4-dihydro-6-(2-naphthyl)-4-oxonicotinic acid and C.sub.1-6 -alkyl esters thereof as well as their alkali metal, alkaline earth metal or ammonium salts are described. The foregoing compounds are useful as central nervous system stimulants. Also described are 1-ethyl-6-(2-naphthyl)-4-oxo-1,4,5,6-tetrahydronicotinic acid and C.sub.1-6 -alkyl esters thereof, which are useful as intermediates.
    Type: Grant
    Filed: July 7, 1980
    Date of Patent: July 14, 1981
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Alexander E. Wick
  • Patent number: 4265893
    Abstract: A composition having diuretic activity which contains a potassium-flushing diuretic and a potassium-retaining compound, said potassium-retaining compound is a compound of the formula ##STR1## wherein R.sup.1 and R.sup.2 are C.sub.1-6 -alkyl or C.sub.2-6 -alkenyl, and R.sup.3 and R.sup.4, independently, are hydrogen, C.sub.1-6 -alkyl, C.sub.2-6 -alkenyl or C.sub.1-6 -acyl, or R.sup.3 and R.sup.4 together with the nitrogen atom are an optionally unsaturated 5-, 6- or 7-membered heterocyclic group, or a physiologically compatible salt thereof, are described.
    Type: Grant
    Filed: September 5, 1979
    Date of Patent: May 5, 1981
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Adam Daum, Michel Fernex, Alexander E. Wick
  • Patent number: 4254286
    Abstract: Benzylpyrimidines of the formula ##STR1## wherein R.sup.1 and R.sup.2, independently, are C.sub.1-6 -alkyl, R.sup.3 is C.sub.1-3 -alkyl and R.sup.4 is methylene or C.sub.2-4 -alkylidene and physiologically compatible acid addition salts thereof, are described. The compounds of formula I are useful as antibacterial agents and as potentiators of sulfonamides.In yet another aspect, the invention relates to intermediates for the preparation of the compounds of formula I.
    Type: Grant
    Filed: October 22, 1979
    Date of Patent: March 3, 1981
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Ivan Kompis, Alexander E. Wick
  • Patent number: 4203980
    Abstract: Benzylpyrimidines of the formula ##STR1## wherein R.sup.1 and R.sup.2, independently, are C.sub.1-6 -alkyl, R.sup.3 isC.sub.1-3 -alkyl and R.sup.4 is methylene or C.sub.2-4 -alkylideneand physiologically compatible acid addition salts thereof, are described. The compounds of formula I are useful as antibacterial agents and as potentiators of sulfonamides.
    Type: Grant
    Filed: April 26, 1978
    Date of Patent: May 20, 1980
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Ivan Kompis, Alexander E. Wick
  • Patent number: 4191758
    Abstract: Benzylpyrimidines of the formula ##STR1## wherein R.sup.1 and R.sup.2, independently, are C.sub.1-3 -alkyl, and R.sup.3 and R.sup.4, independently, are hydrogen or methyl,and physiologically acceptable acid addition salts thereof, are described. The compounds of formula I are useful as antibacterial agents and as potentiators of sulfonamides.
    Type: Grant
    Filed: April 26, 1978
    Date of Patent: March 4, 1980
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Ivan Kompis, Alexander E. Wick
  • Patent number: 4138586
    Abstract: The present disclosure is concerned with a process for the preparation of alkanoyl propionates and alkanoyl propionitriles from .gamma.-nitro-alkanecarboxylic acid esters and alkyl-.gamma.-nitro-propionitriles.
    Type: Grant
    Filed: October 14, 1975
    Date of Patent: February 6, 1979
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Alexander E. Wick
  • Patent number: 4137411
    Abstract: A benzylpyrimidines of the formula ##STR1## wherein r.sup.1 and R.sup.2 independently are C.sub.1-3 -alkyl or C.sub.1-3 -alkoxy, and R is hydrogen or lower alkyl, is treated with hydroxylamine or a salt thereof in polyphosphoric acid or alternatively, when R is hydrogen, is treated with sodium azide in polyphosphoric acid, to yield the corresponding 4-amino benzylpyrimidine.
    Type: Grant
    Filed: February 1, 1978
    Date of Patent: January 30, 1979
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Ivan Kompis, Alexander E. Wick